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The biologist will be confused on the histological
threshold criteria used to diagnose malignancy in
colonic adenomas. For severe dysplasia invading
the mucosal connective tissue but not the
muscularis mucosae 'the most accurate descriptive
term is "intramucosal carcinoma"'. But 'To prevent
confusion the term "intramucosal carcinoma" is
best avoided in the colon.' The authors believe,
perhaps correctly, that metastasis of these lesions
occurs by lymphatic channels only, that there are
none in colonic mucosa and that reporting
'carcinoma' may lead to unnecessary radical
surgery. In consequence suspicious, superficially
invasive lesions will be lumped with the benign for
analysis, and possible variations in risk lost.
Two points will particularly interest those
working with human material. A single prognostic
term can cover different cytological abnormalities
(e.g. severe dysplasia in Figures 122, 128 and 132),
and carcinoma arises in other conditions, whose
cause is often unknown. Are either relevant to the
variety of oncogenes reported?
But perhaps the biologist will be most thoughtful
considering hazards in diagnosis: apparent dysplasia
or pseudoinvasion due to inflammation or
radiation. Would he make a decision with such
risks?
C. Rowlatt
Endocrine Tumours: The Pathobiology ofRegulatory
Peptide-Producing Tumours. By: J.M. POLAK &
S.R. BLOOM. Churchill Livingstone, xi+288 pp,
1985, £35.00. ISBN 0 443 02979 2.
As one who studied pathology in an era when the
glandular cells of the anterior pituitary were
traditionally divided into acidophils, basophils and
chromophobes, this book is a revelation. The
development of new techniques in cell biology -
molecular genetics, monoclonal antibodies, light
and electron microscopic immunocytochemistry, in
situ DNA hybridisation and recombinant DNA
technology have all begun to impinge on our
understanding, histopathological classification and
treatment of endocrine tumours.
Four chapters are devoted to understanding
peptide biosynthetic pathways and three chapters
on new methods of histological examination.
Excellent chapters review the use of in vitro models
for studying the pathobiology of endocrine tumours
and the potential clinical use of neuron-specific
enolase as a tumour marker.
The last third of the book contains four chapters
which consider how our perception of endocrine
tumours of the gut and pancreas, lung, medullary
carcinoma of the thyroid and pituitary adenomas
has been modified using new technology.
My only criticisms are minor. I thought the last
chapter on endocrine syndromes was out of place in
this volume and should have been omitted. In the
chapter on endocrine tumours of gut and pancreas
the authors are confused in their description of
clinical presentation of MEA type I and type II
syndromes and in the introductory chapter the
word thyroid is frequently misspelt.
This is the first volume in a series written for
pathologists. It is expensive at £35, but I would
recommend a copy be purchased by every
pathology department.
S.M. Shalet
Hormone-Producing Tumours of the Gastrointestinal
Tract - Contemporary Issues in Gastroenterology,
Vol. 5. Edited by S. COHEN & R.D. SOLOWAY.
Churchill Livingstone, ix+ 164 pp, 1985, £36.00.
ISBN 0 443 08370 3.
This book on hormone producing gastrointestinal
tumours, deals informatively with the well-
established and the newly-emerging gastrointestinal
- peptidergic - syndromes. The current diagnostic
methods and management of gastronomas is well
presented with a pragmatic approach to treatment.
The chapter on somatostatinomas draws attention
to the newly emerging syndrome associated with
this tumour, which should lead to better
recognition and earlier diagnosis of this disorder,
rather than the present situation of incidental
histological diagnosis postoperatively. The chapters
on glucagon producing tumours and VIPoma
syndrome are very comprehensive, the latter
drawing on what must be one of the largest
personal experience of such tumours. The chapter
on surgical management serves as a concise
overview and briefly discusses carcinoid tumours
and insulinomas. The first chapter gives a general
introduction and the necessary histopathological
background to the subject. It is a useful book for
endocrinologists, gastroenterologists and the
specialist surgeon, though slightly overpriced.
Syed Rafeeq Ahmed
Advances in Cancer Research, Vol. 43. Edited by G.
KLEIN & S. WEINHOUSE. Academic Press, x+320
pp, 1985, £41.00. ISBN 0 12 006643 2.
Review volumes should be up to date, although this
is less important for the non-specialists who wish toBOOK REVIEWS 151
keep abreast of neighbouring fields. This book
contains some 1984 references and is as up to date
as hardbacks ever can be. It also contains the 1876
reference to the first recorded experimental
transplantation of a tumour, the canine
transmissible venereal tumour. Indeed it maintains
the high standard of the previous volumes.
'Cancer Metastasis' by Schirrmacher gives a clear
account of the experimental methods, from in vitro
transfection to various animal models, and a list of
scientific questions. Organ site predilection and
extravasation are discussed briefly but interestingly.
Angiogenesis and vascular distribution is given
more emphasis than lymphatic pathway spread.
Invasion by proteolysis is well discussed.
Immunological intervention in metastasis is
described clearly and somewhat optimistically. The
chapter is good on description but rather short on
criticism. It gives a good introduction to the subject
for new workers in the field.
Cohen's chapter about canine TVT is interesting
in showing that this undifferentiated tumour can be
transmitted by the transplantation of cells into
injured tissue even in immunocompetent allogeneic
dogs. It is believed that this transfer is unique in
nature. The lack of rejection is discussed but not
solved.
Rotter and Wolf discuss the tumour antigen p53.
This protein is present in greater quantity in
transformed than nontransformed cells, and is in
the nucleus of the former but in the cytoplasm of
the latter. Its role in cancer cells is discussed.
Schlom and nine co-authors describe the
approximately two dozen best-characterized mono-
clonal antibodies which are reactive with human
breast tumours. This is a timely progress report in a
fast-moving field; the number of these tumour
'fingerprints' is increasing. The problems of MAbs
for tumour therapy is sensibly discussed.
Folkman's chapter on tumour angiogenesis is a
model of clarity. His five pages on inhibitors of
angiogenesis, as a means of arresting tumour
growth, are interesting but inconclusive. The
marked variation of antiangiogenic activity of
different batches and makes of heparin is
mentioned.
Moelling describes the twenty-two oncogenes in
retroviruses that were known at the time of writing,
and possible mechanisms of transformation.
Szigeti describes the inhibition of migration of
polymorphonuclear granulocytes and macrophages
by LIF and MIF respectively as a test of cellular
immunity in tumours. A table summarising
apparently all of the 45 publications to date on the
application of this test to human breast cancer is
included. The nature and character of the
participating antigen(s) are not understood and
LMI studies cannot distinguish malignant and
benign pathological changes of the breast in a
reliable way. Applications to other solid tumours
are also reported thoroughly, with conflicting
results except in colorectal cancer where the LMI
assay, when combined with other tests, was found
to be promising.
This volume is well worthwhile both for reading
to remain up to date in general and as a source of
references for the particular topics.
J.F. Fowler
Molecular Medicine, Vol. 1. Edited by A.D.B.
MALCOLM. IRL Press, viii+208 pp, 1984, £13.50.
ISBN 0 904147 93 2.
The editor of this new series, Alan Malcolm,
bravely claims in his introduction that 'future
improvements in health care are going to rely
heavily on our understanding of the molecular basis
of the (disease) process'. I do not disagree with this
statement but in the short-term the inability of the
molecular approach to describe the more complex
behaviour of whole organisms has prompted
numerous sterile critiques of the method and its
underlying reductionist philosophy. The success or
failure of Molecular Medicine will be judged by the
degree it demonstrates the real usefulness of
molecular analysis in a wide clinical setting. Is it a
useful area to cover in a series? Unequivocally yes,
as a forum for the two-way exchange of perspective
between clinician and molecular scientist. This is a
role that is not adequately filled by either the
specialist journals nor their occasional review
articles. Does it achieve these aims? The answer
here is that it has probably been pitched too
conservatively with too much emphasis on clinical
activity with no direct relationship to the topic of
Molecular Medicine as opposed to Medicine. This
is, in part, due to the initial choice of topics
covered and in part due to the particular interests
of some of the authors. I would add that all the
articles are of high standard, well produced and of
considerable interest.
The topics covered are fairly disparate and
should, in theory, be connected by the thread of
molecular analysis. This is certainly true of articles
on chromosome rearrangements and cancer,
collagen disorders and the use of NMR in clinical
imaging. Slightly less molecular are articles on
pulmonary emphysema, although much molecular
biology is applied to the a-1 antiprotease
inhibitor, and a very clear review of cholera and
related toxins. However, articles on alpha-
fetoprotein and the renin angiotensin system do not
really exploit molecular analysis and an extremely
readable, albeit bleak and depressing review of the